When harmful bacteria or other microorganisms invade the body, neutrophils, a type of white blood cell, are one of the first immune cells to respond. They release powerful weapons to trap and kill ...

When we recruit our guys, we talk about family, and we talk about making sacrifices for one another, for our teammates.

“The management of vasculitis transcends specialty,” Neil ... seen in the combined outcome endpoint of death and end stage kidney disease. However, post hoc data suggest there could be earlier ...

Page kidney, resulting from the bleeding into the ... of symptoms can make differentiation of PAN from other forms of vasculitis difficult. The American College of Rheumatology created a set ...

They included 296 patients with new-onset or relapsing ANCA-associated vasculitis from four tertiary ... adjusted for renal function. The primary outcome was the incidence of serious infections ...

East Haven High teen faces physical therapy and homework to walk at graduation, inspiring hope and perseverance, after years of mobility issues.

The B-cell inhibitors market is experiencing robust growth, driven by the rising prevalence of the addressable patient population, which incl ...

This is the most common form of vasculitis seen in lupus and it is fairly common in dermatomyositis and scleroderma, but less common in rheumatoid arthritis. The small vessels are at your fingertips ...

CLEVELAND, May 19, 2025 (GLOBE NEWSWIRE) -- NovelMed is pleased to announce positive 12-week interim results from the ongoing multi-dose Phase II trial of Ruxoprubart, a novel complement-targeting ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the ...